home / stock / cntg / cntg news

CNTG News and Press, Centogene N.V. From 03/19/24

Stock Information
Company Name: Centogene N.V.
Stock Symbol: CNTG
Market: NYSE
Website: centogene.com
Menu
CNTG CNTG Quote CNTG Short CNTG News CNTG Articles CNTG Message Board
Get CNTG Alerts

News, Short Squeeze, Breakout and More Instantly...
CNTG - Centogene, Takeda extend diagnostic partnership

2024-03-19 07:41:32 ET More on Centogene, Takeda, etc. Takeda Pharmaceutical: Eohilia's FDA Approval Brings Tailwinds Takeda Pharmaceutical Company: Attractive Stock But Needs To Grow Net Profits Takeda Pharmaceutical Company Limited 2023 Q3 - Results - Earnings Call...
CNTG - CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCR? Deficiency

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the publication in Science of res...

CNTG - CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that the Company received a staf...

CNTG - CENTOGENE Explores Strategic Alternatives

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that the Company has decided to explo...
CNTG - CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and the Laboratory of Human Genetics of Infectious Di...

CNTG - CENTOGENE Receives French Research Tax Credit Accreditation

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has been recognized by the French Ministry of Higher Educa...

CNTG - CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson's Disease Using Multiomics

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and The Michael J. Fox Foundation for Parkinson’s Research (MJFF), a non-pr...
CNTG - Centogene says FY revenue is expected to be between Euro48.5 million Euro49.0 million

2024-01-18 07:11:53 ET More on Centogene Seeking Alpha’s Quant Rating on Centogene Historical earnings data for Centogene Financial information for Centogene For further details see: Centogene says FY revenue is expected to be between €48.5 ...

CNTG - CENTOGENE Announces Preliminary Full Year 2023 Revenue

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced preliminary unaudited revenue for full year 2023 between approximat...

CNTG - Motus GI, C4 Therapeutics among healthcare movers

2023-12-13 10:00:34 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Motus GI, C4 T...
Previous 10 Next 10